A coated implantable medical device 10 includes a structure 12 adapted for introduction into the vascular system, esophagus, trachea, colon, biliary tract, or urinary tract; at least one coating layer 16 posited on one surface of the structure; and at least one layer 18 of a bioactive material posit
A coated implantable medical device 10 includes a structure 12 adapted for introduction into the vascular system, esophagus, trachea, colon, biliary tract, or urinary tract; at least one coating layer 16 posited on one surface of the structure; and at least one layer 18 of a bioactive material posited on at least a portion of the coating layer 16, wherein the coating layer 16 provides for the controlled release of the bioactive material from the coating layer. In addition, at least one porous layer 20 can be posited over the bioactive material layer 18, wherein the porous layer includes a polymer and provides for the controlled release of the bioactive material therethrough. Preferably, the structure 12 is a coronary stent. The porous layer 20 includes a polymer applied preferably by vapor or plasma deposition and provides for a controlled release of the bioactive material. It is particularly preferred that the polymer is a polyamide, parylene or a parylene derivative, which is deposited without solvents, heat or catalysts, and merely by condensation of a monomer vapor.
대표청구항▼
What is claimed is: 1. A method of making a coated implantable medical device, comprising the steps of: providing a structure adapted for introduction into a human or veterinary patient, the structure being composed of a base material forming a surface; positioning a coating layer over the surface;
What is claimed is: 1. A method of making a coated implantable medical device, comprising the steps of: providing a structure adapted for introduction into a human or veterinary patient, the structure being composed of a base material forming a surface; positioning a coating layer over the surface; applying a bioactive material comprising a peptide over the surface of the structure by dipping at least a portion of the coating layer positioned over the surface in a fluid mixture comprising the bioactive material; and positioning at least one porous layer over the bioactive material and the coating layer, the porous layer controlling the release of the bioactive material from the medical device. 2. The method of claim 1, wherein porous layer has a thickness of about 5,000 to 250,000 Angstroms. 3. The method of claim 1, wherein coating layer has a thickness of about 50,000 to 500,000 Angstroms. 4. The method of claim 1, wherein the total amount of bioactive material applied is about 0.1 to 4 mg/cm2 of the surface. 5. The method of claim 1, wherein the bioactive material comprises an antibody. 6. The method of claim 1, wherein the coating layer consists essentially of phosphatidylcholine. 7. The method of claim 1, wherein the structure is configured as a vascular stent comprising a biocompatible metal base material; the coating layer comprises phosphatidylcholine and has a thickness of about 50,000 to 500,000 Angstroms; the bioactive material comprises an antibody and the total amount of bioactive applied is about 0.1 to 4 mg/cm2 of the surface; and the porous layer has a thickness of about 5,000 to 250,000 Angstroms. 8. The method of claim 1, where the coated implantable medical device contains at least about 0.01 micrograms of the bioactive material per mm2 of the surface; the total amount of the bioactive material applied to the medical device is about 0.1 to 4 mg/cm2 of the surface of the coated implantable medical device; and the coated medical device releases at least half of the bioactive material after perfusion for about 10 days in 1% bovine serum albumin (BSA) in phosphate buffered saline (PBS) at about 10 ml/minute. 9. A method of making a coated implantable medical device, comprising the steps of: providing a vascular stent adapted for introduction into a blood vessel of a human or veterinary patient, the vascular stent being composed of a base material forming a surface comprising a biocompatible metal; positioning a coating layer over the surface; applying a bioactive material comprising an antibody over at least a portion of the structure by dipping at least a portion of the coating layer positioned over the surface in a fluid mixture comprising the bioactive material; and positioning a porous layer over the bioactive material and the coating layer, the porous layer having a thickness effective to provide a controlled release of the bioactive material through the porous layer. 10. The method of claim 9, further comprising the step of positioning a porous layer comprising phosphatidylcholine over the bioactive material and the coating layer; and the total amount of bioactive material applied to the medical device is about 0.1 to 4 mg/cm2 of the surface of the coated implantable medical device. 11. The method of claim 10, wherein the coating layer comprises phosphatidylcholine and has a thickness of about 50,000 to 500,000 Angstroms; the bioactive material comprises a GP IIb/IIIa antibody and the total amount of bioactive applied to the medical device is at least about 0.01 micrograms of the antibody per mm2 of the surface; and the porous layer comprises phosphatidylcholine, and has a thickness of about 5,000 to 250,000 Angstroms. 12. A method of making a coated implantable medical device, comprising the steps of: providing a structure adapted for introduction into a human or veterinary patient, the structure being composed of a base material forming a surface; positioning a coating layer over the surface; and applying a bioactive material comprising a peptide over at least a portion of the structure by contacting a fluid mixture comprising the bioactive material with at least a portion of the coating layer positioned over the surface; positioning at least one porous layer comprising phosphatidylcholine over the bioactive material, the porous layer providing for a controlled release of the bioactive material through the porous layer. 13. A method of controlling the release of a bioactive material from an implantable medical device having a structure composed of a base material forming a surface and being adapted for introduction into a human or veterinary patient, the method comprising the steps of: positioning a coating layer of an adsorbent or absorbent material over the surface; attaching a bioactive material comprising a peptide to the coating layer by dipping at least a portion of the coating layer positioned over the surface in a fluid mixture comprising the bioactive material; and positioning at least one porous layer over the bioactive material and the coating layer to form a coated medical device, the porous layer controlling the release of the bioactive material from the coated medical device. 14. The method of claim 13, where the bioactive material comprises an antibody and the coated medical device releases at least half of the bioactive material after perfusion for about 10 days in 1% bovine serum albumin (BSA) in phosphate buffered saline (PBS) at about 10 ml/minute. 15. The method of claim 14, where the porous layer comprises phosphatidylcholine. 16. The method of claim 15, where the coating layer has a thickness of about 50 to 500,000 Angstroms. 17. The method of claim 13, wherein the bioactive material comprises a protein. 18. The method of claim 13, wherein the bioactive material comprises an antibody. 19. The method of claim 13, wherein the bioactive material comprises a GP IIb/IIIa antibody. 20. The method of claim 13, wherein the coating layer comprises phosphatidylcholine. 21. The method of claim 13, wherein the base material comprises one or more materials selected from the group consisting of: stainless steel, tantalum, titanium, nitinol, gold, platinum, a biocompatible metal alloy, iridium, silver, tungsten, carbon, carbon fiber, cellulose acetate, cellulose nitrate, silicone, polyethylene teraphthalate, polyurethane, polyamide, polyester, polyorthoester, polyanhydride, polyether sulfone, polycarbonate, polypropylene, polyethylene, polytetrafluoroethylene, polylactic acid, polyglycolic acid, a polyanhydride, polycaprolactone, polyhydroxybutyrate valerate extracellular matrix, collagen, and fibrin. 22. The method of claim 13, wherein the medical device is configured as a vascular stent. 23. The method of claim 13, wherein the medical device is configured as a vascular stent; the porous layer comprises phosphatidylcholine; and the coating layer comprises phosphatidylcholine; the bioactive material comprises a material selected from the group consisting of; a protein and an antibody; and the base material comprises one or more materials selected from the group consisting of: stainless steel, tantalum, titanium, nitinol, gold, platinum, a biocompatible metal alloy, iridium, silver, tungsten, carbon, carbon fiber, cellulose acetate, cellulose nitrate, silicone, polyethylene teraphthalate, polyurethane, polyamide, polyester, polyorthoester, polyanhydride, polyether sulfone, polycarbonate, polypropylene, polyethylene, polytetrafluoroethylene, polylactic acid, polyglycolic acid, a polyanhydride, polycaprolactone, polyhydroxybutyrate valerate extracellular matrix, collagen, and fibrin.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (123)
Benjamin John D. (Malvern GB2) Mears Adrian L. (Cheltenham GB2) White John C. (Lincoln GB2), Active silicon implant devices.
Domb Abraham J. (Baltimore MD) Shikani Alain (Baltimore MD) Haffer Andrew S. T. (Baltimore MD) Maniar Manoj (Baltimore MD), Anti-infective and anti-inflammatory releasing systems for medical devices.
Solomon Donald D. (Spring Valley OH) Byron M. Parke (Centerville OH), Anti-infective and antithrombogenic medical articles and method for their preparation.
Khan Mohammad A. (Sandy UT) Solomon Donald D. (Spring Valley OH) Byron Matthew P. (Centerville OH), Anti-infective and lubricious medical articles and method for their preparation.
Sawamoto Jiro (Fuji JPX) Takano Yoshihito (Fuji JPX) Ezaki Yuzo (Fuji JPX), Antithrombic medical material, artificial internal organ, and method for production of antithrombic medical material.
Cahalan Linda L. (Geleen NLX) Cahalan Patrick T. (Geleen NLX) Verhoeven Michel (Maastricht NLX) Hendriks Marc (Hoensbroek NLX) Fouache Benedicte (Maastricht NLX), Biocompatible medical article and method.
Buscemi Paul J. (Long Lake MN) Stejskal Elizabeth A. (St. Paul MN) Palme ; II Donald F. (Dayton MN) Wang Lixiao (St. Paul MN), Biodegradable drug delivery vascular stent.
Buscemi Paul J. (Long Lake MN) Stejskal Elizabeth A. (St. Paul MN) Palme ; II Donald F. (Dayton MN) Wang Lixiao (St. Paul MN), Biodegradable drug delivery vascular stent.
Eugene P. Goldberg ; Ali Yahiaoui ; Khalid Mentak MA; Theresa Rivero Erickson ; James Seeger, Biofunctional surface modified ocular implants, surgical instruments, medical devices, prostheses, contact lenses and the like.
Myler Richard (828 Irwin Dr. Hillsborough CA 94010) Hammerslag Julius G. (27011 Calle Esperanza San Juan Capistrano CA 92675), Cardiovascular stent and retrieval apparatus.
Bates, Brian L.; Ragheb, Anthony O.; Stewart, IV, Joseph M.; Bourdeau, William J.; Choules, Brian D.; Purdy, James D.; Fearnot, Neal E., Coated implantable medical device.
Fearnot Neal E. (West Lafayette IN) Kozma Thomas G. (West Lafayette IN) Ragheb Anthony O. (West Lafayette IN) Voorhees William D. (West Lafayette IN), Coated implantable medical device.
Ragheb, Anthony O.; Bates, Brian L.; Fearnot, Neal E.; Kozma, Thomas G.; Voorhees, III, William D.; Gershlick, Anthony H., Coated implantable medical device.
Martin Ulrich (Mannheim DEX) Fischer Stephan (Polling DEX), Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof..
Kopia Gregory A. (Phoenixville PA) Horan Paul K. (Downingtown PA) Gray Brian D. (Ardmore PA) Troutner David E. (Phoenixville PA) Muirhead Katharine A. (West Chester PA) Sheth Kamleshkumar A. (Downing, Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles.
Greco Ralph S. (Princeton NJ) Harvey Richard A. (East Brunswick NJ) Trooskin Stanley Z. (North Brunswick NJ), Drug bonded prosthesis and process for producing same.
Eury Robert P. (Cupertino CA) Garguilo Darlene (Fremont CA) Villareal Plaridel (San Jose CA), Drug loaded polymeric material and method of manufacture.
Everse Johannes (2613 Newcomb St. Lubbock TX 79430) Everse Kathleen E. (2613 Newcomb St. Lubbock TX 79430) Mercer Leo C. (4800 Alberta El Paso TX 79912), Immobilization of Streptokinase.
Matsuda Takehisa (Minou JPX) Nakayama Yasuhide (Minou JPX) Sugawara Takashi (Ikeda JPX), Immobilization of an anti-thrombogenic substance with a photo-reactive azide and a photo-crosslinking material.
Fox ; Jr. Charles L. (New York NY) Modak Shanta M. (River Edge NJ) Sampath Lester A. (Nyack NY), Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same.
Gruskin Elliott A. (East Norwalk CT) Lee Daniel R. (Madison CT) Brown Lloyd S. (Guilford CT), Infection-resistant surgical devices and methods of making them.
Schwartz Robert S. (Rochester MN) Bresnahan John (Rochester MN) Bergman Rebecca M. (North Oaks MN) Coury Arthur J. (St. Paul MN) Lindell Elaine (Blaine MN) Hull Vincent W. (Fridley MN), Intravascular radially expandable stent.
Fischell Robert E. (Silver Spring MD) Fischell Tim A. (Palo Alto CA), Intravascular stent and percutaneous insertion catheter system for the dilation of an arterial stenosis and the preventi.
Domb Abraham J. (Efrat MD ILX) Shikani Alain H. (Ruxton MD), Method and device for inhibiting HIV, hepatitis B and other viruses and germs when using a catheter in a medical environ.
March Keith L. (Carmel IN) Hathaway David R. (Indianapolis IN) Wilensky Robert L. (Indianapolis IN), Method for delivery of smooth muscle cell inhibitors.
Frautschi Jack (Grand Prairie TX) Tingey Kevin (Salt Lake City UT), Methods and compositions for providing articles having improved biocompatability characteristics.
Cullinan George J. (Trafalgar IN) Singh Jai P. (Carmel IN) Wood Dan L. (Indianapolis IN), Methods for inhibiting vascular smooth muscle cell proliferation and restinosis.
Thulesius Olav (P.O. Box 24923 Kuwait 13110 KWX) Christenson Jan T. (P.O. Box 24923 Kuwait 13110 KWX), Methods for preventing thrombosis; and surgical implant having reduced platelet deposition characteristics.
Winters Suzanne (Salt Lake City UT) Solen Kenneth A. (Orem UT) Sanders Clifton G. (Salt Lake City UT) Mortensen J. D. (Sandy UT) Berry Gaylord (Salt Lake City UT), Multifunctional thrombo-resistant coatings and methods of manufacture.
Tartaglia Joseph M. (Redwood City CA) Loeffler Joseph P. (Mountain View CA) Turnlund Todd H. (Mountain View CA), Polymer film for wrapping a stent structure.
Marchant Roger E. (Shaker Hts. OH), Process for producing hydroxylated plasma-polymerized films and the use of the films for enhancing the compatiblity of b.
Burrell Robert E. (Sherwood Park CAX) McIntosh Catherine L. (Sherwood Park CAX) Morris Larry R. (Yarker CAX), Process of activating anti-microbial materials.
Ragheb Anthony O. ; Bates Brian L. ; Fearnot Neal E. ; Osborne Thomas A. ; Kozma Thomas G. ; Roberts Joseph W. ; Voorhees ; III William D., Silver implantable medical device.
Scott Neal A. (Atlanta GA) Hanson Stephen R. (Stone Mountain GA) King ; III Spencer B. (Atlanta GA) Harker Laurence A. (Atlanta GA), Stent sheath for local drug delivery.
Fearnot Neal E. (West Lafayette IN) Ragheb Anthony O. (West Lafayette IN) Voorhees ; III William D. (West Lafayette IN), Thrombolytic treated intravascular medical device.
Miklas, Jason; Radisic, Milica; Thavandiran, Nimalan; Vasconcelos, Sara; Xiao, Yun; Zhang, Boyang; Zhao, Yimu, Compositions and methods for making and using three-dimensional tissue systems.
Xia, Jusong; Trieu, Hai H.; McKay, William F.; Metcalf, Jr., Newton H.; Kerr, Nikolas F.; Amery, Drew, Preformed drug-eluting device to be affixed to an anterior spinal plate.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.